Topic:

Emerging Markets

Latest Headlines

Latest Headlines

Serum Institute sets out for dengue fast track

Asia's largest vaccinemaker just made a play that could affect the race for a vaccine protecting against dengue fever, a common affliction that has a big impact in the region.

GE Healthcare creates an emerging markets unit with $300M commitment

GE Healthcare has staked a major claim in a field that's not well tended--the development of affordable medical technologies to improve health outcomes in the emerging markets. It's creating a devoted business called Sustainable Healthcare Solutions out of a combination of its operations in India, South Asia, Africa and Southeast Asia dedicated to serving 70 markets--and investing $300 million to back the effort.

LabCorp-backed Ativa gets $15M to bring diagnostics to the doctor's office in emerging markets

The middle class in emerging market countries wants diagnostics--and Minneapolis, MN-based Ativa Medical plans to bring it to them via a point-of-care, micro lab designed for the physician office. The startup has secured a $15 million Series B round that's intended to support gaining FDA approval for its micro lab and preparing for commercial launch.

China's Mindray falls as execs reduce their take-private offer

Mindray Medical was off in early trading on the news that a management buyout that was first proposed in June now has a reduced price. The latest offer was for $27 per ADS; that's down from the original offer of $30 per ADS.

Glaxo starts $153M plant in India

GlaxoSmithKline has started work on a new plant in India that is expected to bring hundreds of jobs to the Bangalore area. In the interim, the company's investment for the tablet facility, which will incorporate continuous processing, has grown to £100 million from the £85 initially projected.

Roche CEO: Despite China worries, emerging markets will continue to deliver growth

Roche CEO Severin Schwan isn't worried about the company's progress in emerging markets. While the helmsman acknowledged a slowdown in China and currency issues in Brazil, the company is still on track to post growth in the long term, Schwan said in an interview with Bloomberg.

China FDA signs off on 3-D printed hip implants

The Chinese Food and Drug Administration approved 3-D printed hip implants in China, encouraging innovation amid an increasingly stringent regulatory environment.

Mega Lifesciences to expand in Indonesia on partnership with Sydna Farma

Thailand-based pharma manufacturer Mega Lifesciences is partnering with Sydna Farma of Singapore as part of its efforts to expand into Indonesia.

Researchers ready consumer STD-detecting, connected ring for Indiegogo in early 2016

An international entrepreneurial trio has developed a hand-worn ring that detects syphilis, gonorrhea, chlamydia and trichomoniasis--wirelessly transmitting the results to a smartphone or tablet in under one minute. Known as Hoope, the device has a retractable needle and an anesthetic system based on electrical pulses; it is slated to debut on crowdfunding site Indiegogo in January.

Big Pharma, rejoice: China aims to speed up approvals for new meds

Relations between China and foreign drugmakers have been thawing for a while, with the country announcing late last year that it would toss out restrictive price caps and streamline drug approvals for companies. Now, China is throwing multinational drugmakers another bone as it plans to reduce lengthy approval times for innovative drugs.  
'